Current Hypertension Reviews最新文献

筛选
英文 中文
Endothelial Dysfunction Induced by Cadmium and Mercury and its Relationship to Hypertension. 镉、汞所致内皮功能障碍及其与高血压的关系。
IF 2.3
Current Hypertension Reviews Pub Date : 2021-01-01 DOI: 10.2174/1573402117666210121102405
Airton C Martins, Alessanda A D Santos, Ana C B A Lopes, Anatoly V Skalny, Michael Aschner, Alexey A Tinkov, Monica M B Paoliello
{"title":"Endothelial Dysfunction Induced by Cadmium and Mercury and its Relationship to Hypertension.","authors":"Airton C Martins,&nbsp;Alessanda A D Santos,&nbsp;Ana C B A Lopes,&nbsp;Anatoly V Skalny,&nbsp;Michael Aschner,&nbsp;Alexey A Tinkov,&nbsp;Monica M B Paoliello","doi":"10.2174/1573402117666210121102405","DOIUrl":"https://doi.org/10.2174/1573402117666210121102405","url":null,"abstract":"<p><p>Hypertension is an important public health concern that affects millions globally, leading to a large number of morbidities and fatalities. The etiology of hypertension is complex and multifactorial, and it involves environmental factors, including heavy metals. Cadmium and mercury are toxic elements commonly found in the environment, contributing to hypertension. We aimed to assess the role of cadmium and mercury-induced endothelial dysfunction in the development of hypertension. A narrative review was carried out through database searches. In this review, we discussed the critical roles of cadmium and mercury in the etiology of hypertension and provided new insights into potential mechanisms of their effect, focusing primarily on endothelial dysfunction. Although the mechanisms by which cadmium and mercury induce hypertension have yet to be completely elucidated, evidence for both implicates impaired nitric oxide signaling in their hypertensive etiology.</p>","PeriodicalId":45941,"journal":{"name":"Current Hypertension Reviews","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38842825","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
Phyto-derived Products as Matrix Metalloproteinases Inhibitors in Cardiovascular Diseases. 植物衍生产品作为基质金属蛋白酶抑制剂在心血管疾病中的应用。
IF 2.3
Current Hypertension Reviews Pub Date : 2021-01-01 DOI: 10.2174/1573402116666200510011356
Alejandro F do Prado, Cahy M Bannwart, Victoria M T Shinkai, Ildercílio M de Souza Lima, César A Meschiari
{"title":"Phyto-derived Products as Matrix Metalloproteinases Inhibitors in Cardiovascular Diseases.","authors":"Alejandro F do Prado,&nbsp;Cahy M Bannwart,&nbsp;Victoria M T Shinkai,&nbsp;Ildercílio M de Souza Lima,&nbsp;César A Meschiari","doi":"10.2174/1573402116666200510011356","DOIUrl":"https://doi.org/10.2174/1573402116666200510011356","url":null,"abstract":"<p><p>Matrix metalloproteinases (MMPs) are enzymes that present a metallic element in their structure. These enzymes are ubiquitously distributed and function as extracellular matrix (ECM) remodelers. MMPs play a broad role in cardiovascular biology regulating processes such as cell adhesion and function, cellular communication and differentiation, integration of mechanical force and force transmission, tissue remodeling, modulation of damaged-tissue structural integrity, cellular survival or apoptosis and regulation of inflammation-related cytokines and growth factors. MMPs inhibition and downregulation are correlated with minimization of cardiac damage, i.e., Chinese herbal medicine has shown to stabilize abdominal aorta aneurysm due to its antiinflammatory, antioxidant and MMP-2 and 9 inhibitory properties. Thus phyto-derived products rise as promising sources for novel therapies focusing on MMPs inhibition and downregulation to treat or prevent cardiovascular disorders.</p>","PeriodicalId":45941,"journal":{"name":"Current Hypertension Reviews","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37915904","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Beta Blockers and Chronic Obstructive Pulmonary Disease (COPD): Sum of Evidence. -受体阻滞剂和慢性阻塞性肺疾病(COPD):证据总结。
IF 2.3
Current Hypertension Reviews Pub Date : 2021-01-01 DOI: 10.2174/1573402116999201209203250
Katerina Baou, Vasiliki Katsi, Thomas Makris, Dimitris Tousoulis
{"title":"Beta Blockers and Chronic Obstructive Pulmonary Disease (COPD): Sum of Evidence.","authors":"Katerina Baou,&nbsp;Vasiliki Katsi,&nbsp;Thomas Makris,&nbsp;Dimitris Tousoulis","doi":"10.2174/1573402116999201209203250","DOIUrl":"https://doi.org/10.2174/1573402116999201209203250","url":null,"abstract":"<p><p>Approximately half a century has passed since the discovery of beta-blockers. Then, their prime therapeutic purpose was to treat angina and cardiac arrhythmias; nowadays, beta-blockers' usage and effectiveness are extended to treat other cardiovascular diseases, such as hypertension, congestive heart failure, and coronary artery disease. Safety concerns were raised about beta- blockers and their use for chronic obstructive pulmonary disease (COPD) patients with concurrent cardiovascular disease. After thorough research of the literature, this review summarizes the evidence proving that beta-blockers not only might be well tolerated in COPD patients, but they might also have a beneficial effect in this group of patients.</p>","PeriodicalId":45941,"journal":{"name":"Current Hypertension Reviews","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38697522","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Pesticides-induced Cardiovascular Dysfunctions: Prevalence and Associated Mechanisms. 农药诱导的心血管功能障碍:患病率和相关机制。
IF 2.3
Current Hypertension Reviews Pub Date : 2021-01-01 DOI: 10.2174/1573402117666210111102508
Joseph A Adeyemi, Victor O Ukwenya, Olatunbosun K Arowolo, Christian C Olise
{"title":"Pesticides-induced Cardiovascular Dysfunctions: Prevalence and Associated Mechanisms.","authors":"Joseph A Adeyemi,&nbsp;Victor O Ukwenya,&nbsp;Olatunbosun K Arowolo,&nbsp;Christian C Olise","doi":"10.2174/1573402117666210111102508","DOIUrl":"https://doi.org/10.2174/1573402117666210111102508","url":null,"abstract":"<p><p>Increased applications of pesticides, mainly in agriculture and public health, have resulted in increased chances of human exposure to pesticides. Chronic exposure to pesticides has been implicated in several human diseases, including cardiovascular diseases. Cardiovascular diseases are broadly used for various heart pathological conditions, including a defect in blood vessels, and they include myocardial infarction, atherosclerosis, stroke, cardiomyopathy, coronary heart disease, etc. In this review, the association between human exposure to pesticides and the development of cardiovascular diseases was discussed using epidemiological and laboratory data. The toxicokinetics of pesticides in humans was reviewed, as well as the risk factors for cardiovascular diseases. The important role of oxidative stress principally the induction of reactive oxygen species as the signaling molecules for various signaling pathways involved in pesticides-induced cardiovascular disease, was discussed.</p>","PeriodicalId":45941,"journal":{"name":"Current Hypertension Reviews","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38741673","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
Ambulatory Blood Pressure Monitoring in the Diagnosis and Management of Arterial Hypertension in Current Medical Practice in Algeria. 动态血压监测在诊断和管理动脉高血压在阿尔及利亚目前的医疗实践。
IF 2.3
Current Hypertension Reviews Pub Date : 2021-01-01 DOI: 10.2174/1573402116666200324144223
Naima Hammoudi-Bendib, Leila Manamani, Souhila Ouabdesselam, Dalila S Ouamer, Sofiane Ghemri, Laurene Courouve, Amine Cherif, Lamine Mahi, Salim Benkhedda
{"title":"Ambulatory Blood Pressure Monitoring in the Diagnosis and Management of Arterial Hypertension in Current Medical Practice in Algeria.","authors":"Naima Hammoudi-Bendib,&nbsp;Leila Manamani,&nbsp;Souhila Ouabdesselam,&nbsp;Dalila S Ouamer,&nbsp;Sofiane Ghemri,&nbsp;Laurene Courouve,&nbsp;Amine Cherif,&nbsp;Lamine Mahi,&nbsp;Salim Benkhedda","doi":"10.2174/1573402116666200324144223","DOIUrl":"https://doi.org/10.2174/1573402116666200324144223","url":null,"abstract":"<p><strong>Objective: </strong>There are limited data on the management of hypertension (HT) in Algeria. The aim of this study was to assess, in current medical practice, the use and benefits of ambulatory blood pressure monitoring (ABPM) for the diagnosis and management of HT.</p><p><strong>Methods: </strong>A prospective, observational, multicenter study was performed in 2017. Patients aged ≥ 18 years with suspected or treated HT were included. A 24-hour ABPM was performed at baseline in all patients. Therapeutic decision was taken by the physician according to ABPM results and patients were then followed up to 6 weeks.</p><p><strong>Results: </strong>The analysis included 1027 patients (mean age, 51.0 years; women, 61.6%) with treated HT (37.3%) or suspected HT (62.7%). Major cardiovascular risk factors were diabetes (15.7%) and lipid disorders (7.2%). ABPM was pathological in 55.1% of patients on antihypertensive treatment and in 60.8% of patients with suspected HT. A therapeutic adjustment or a treatment switch was performed after pathological ABPM in 37.4% of patients already on antihypertensive treatment and an antihypertensive therapy was initiated in 54.9% of patients with initially suspected HT.</p><p><strong>Conclusion: </strong>This study is the first evaluation of the usefulness of ABPM for the management of HT in Algeria. Our results emphasize that ABPM is a highly valuable method for avoiding the whitecoat effect and for detecting patients who are insufficiently treated with antihypertensive drugs.</p>","PeriodicalId":45941,"journal":{"name":"Current Hypertension Reviews","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37768194","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Serum Uric Acid and Progression of Autosomal Dominant Polycystic Kidney Disease: Results from the HALT PKD Trials. 血清尿酸与常染色体显性多囊肾病的进展:来自HALT PKD试验的结果
IF 2.3
Current Hypertension Reviews Pub Date : 2021-01-01 DOI: 10.2174/1573402116666200817113125
Godela M Brosnahan, Zhiying You, Wei Wang, Berenice Y Gitomer, Michel Chonchol
{"title":"Serum Uric Acid and Progression of Autosomal Dominant Polycystic Kidney Disease: Results from the HALT PKD Trials.","authors":"Godela M Brosnahan,&nbsp;Zhiying You,&nbsp;Wei Wang,&nbsp;Berenice Y Gitomer,&nbsp;Michel Chonchol","doi":"10.2174/1573402116666200817113125","DOIUrl":"https://doi.org/10.2174/1573402116666200817113125","url":null,"abstract":"<p><strong>Background: </strong>Epidemiological studies have suggested that elevated serum uric acid may contribute to the progression of chronic kidney disease. However, no large prospective study has examined whether hyperuricemia is an independent risk factor for the progression of autosomal dominant polycystic kidney disease (ADPKD).</p><p><strong>Methods: </strong>We measured uric acid in stored serum samples from the 2-year study visit of 671 participants from the HALT PKD multicenter trials. Participants were categorized according to uric acid tertiles. For Study A (participants aged 15-49 years with preserved kidney function, n=350), we used linear mixed effects models to examine the association between uric acid and repeated measures of height-adjusted total kidney volume (htTKV), the primary outcome for Study A. For Study B (participants aged 18-64 with decreased kidney function, n=321), we used Cox proportional hazards models to assess the hazard for the combined endpoint of 50% loss in estimated glomerular filtration rate (eGFR), end-stage kidney disease (ESKD), or death, the primary outcome for Study B. To assess the association of uric acid with the slope of eGFR decline (secondary outcome of HALT A and B), we used linear mixed effects models for the combined population of Study A and B.</p><p><strong>Results: </strong>In the unadjusted model, the annual change in htTKV was 2.7% higher in the highest uric acid tertile compared to the lowest (p<0.001), but this difference became insignificant after adjustment for gender. Men had faster TKV growth than women (p<0.001). There was no difference in eGFR decline between the 3 uric acid tertiles. Hazard ratios for the clinical endpoint were 2.9 (95% confidence interval, 1.9-4.4) and 1.8 (1.1-2.8) respectively in the high and medium uric acid groups in unadjusted and partially adjusted models (p<0.001), but the significance was lost after adjustment for baseline eGFR. Results were similar when uric acid was examined as a continuous variable.</p><p><strong>Conclusion: </strong>Elevated serum uric acid is not an independent risk factor for disease progression in ADPKD.</p>","PeriodicalId":45941,"journal":{"name":"Current Hypertension Reviews","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7887140/pdf/nihms-1629002.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38275292","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Endogenous Bufadienolide, Blood Pressure and Alcohol Withdrawal. 内源性丁二烯内酯对血压和戒酒的影响。
IF 2.3
Current Hypertension Reviews Pub Date : 2021-01-01 DOI: 10.2174/1573402116999200819162306
Vladimir A Kashkin, Alexei Y Egorov, Evgeniy M Krupitsky, Alexei Y Bagrov
{"title":"Endogenous Bufadienolide, Blood Pressure and Alcohol Withdrawal.","authors":"Vladimir A Kashkin,&nbsp;Alexei Y Egorov,&nbsp;Evgeniy M Krupitsky,&nbsp;Alexei Y Bagrov","doi":"10.2174/1573402116999200819162306","DOIUrl":"https://doi.org/10.2174/1573402116999200819162306","url":null,"abstract":"<p><strong>Background and objective: </strong>Previously, it was demonstrated that marinobufagenin (MBG) is implicated in the development of ethanol withdrawal in rats. It has been shown that ethanol withdrawal is associated with a pressor response in the alcoholics. We hypothesized that elevated levels of sodium pump ligand, MBG, would underline the increase in systolic blood pressure during alcohol withdrawal in humans.</p><p><strong>Methods: </strong>The cohort included 9 patients with the diagnosis \"alcohol dependence syndrome\" (F10.(1-3) according to ICD-10). The blood samples for measurement of MBG concentration were collected from the subjects on the first day of withdrawal and after 7 days treatment of the abstinence. Arterial blood pressure was measured via plethysmography at the same time points.</p><p><strong>Results: </strong>The beginning of the alcoholic abstinence was associated with the rise of arterial blood pressure with enhanced levels of plasma MBG. At day 7 following withdrawal, the systolic blood pressure and MBG levels were decreased to normal values.</p><p><strong>Conclusion: </strong>The development of alcohol withdrawal is accompanied by an increase in arterial blood pressure, which is associated with increased plasma MBG concentration.</p>","PeriodicalId":45941,"journal":{"name":"Current Hypertension Reviews","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38282627","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Perivascular Adipose Tissue Oxidative Stress on the Pathophysiology of Cardiometabolic Diseases 血管周围脂肪组织氧化应激对心脏代谢性疾病病理生理学的影响
IF 2.3
Current Hypertension Reviews Pub Date : 2020-12-01 DOI: 10.2174/15734021otc5koti1tcvy
Ana P. Davel
{"title":"Perivascular Adipose Tissue Oxidative Stress on the Pathophysiology of Cardiometabolic Diseases","authors":"Ana P. Davel","doi":"10.2174/15734021otc5koti1tcvy","DOIUrl":"https://doi.org/10.2174/15734021otc5koti1tcvy","url":null,"abstract":"","PeriodicalId":45941,"journal":{"name":"Current Hypertension Reviews","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2020-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43278582","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endothelium: A Target for Harmful Actions of Metals 内皮:金属有害作用的靶点
IF 2.3
Current Hypertension Reviews Pub Date : 2020-12-01 DOI: 10.2174/15734021otu4emtmctcvy
D. Vassallo
{"title":"Endothelium: A Target for Harmful Actions of Metals","authors":"D. Vassallo","doi":"10.2174/15734021otu4emtmctcvy","DOIUrl":"https://doi.org/10.2174/15734021otu4emtmctcvy","url":null,"abstract":"","PeriodicalId":45941,"journal":{"name":"Current Hypertension Reviews","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2020-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47602464","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Meet Our Editorial Board Member. 见见我们的编辑委员会成员。
IF 2.3
Current Hypertension Reviews Pub Date : 2020-09-03 DOI: 10.2174/157340211202160525000755
M. Mogi
{"title":"Meet Our Editorial Board Member.","authors":"M. Mogi","doi":"10.2174/157340211202160525000755","DOIUrl":"https://doi.org/10.2174/157340211202160525000755","url":null,"abstract":"","PeriodicalId":45941,"journal":{"name":"Current Hypertension Reviews","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2020-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41819955","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信